Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study.

Sobue Y, Kojima T, Kurokouchi K, Takahashi S, Yoshida H, Poole R, Ishiguro N.

Arthritis Res Ther. 2017 Dec 6;19(1):265. doi: 10.1186/s13075-017-1471-1.

2.

Energy drinks and adolescents - A hepatic health hazard?

Robin S, Buchanan R, Poole R.

J Hepatol. 2018 Apr;68(4):856-857. doi: 10.1016/j.jhep.2017.10.036. Epub 2017 Nov 23. No abstract available.

PMID:
29175287
3.

Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.

Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J.

BMJ. 2017 Nov 22;359:j5024. doi: 10.1136/bmj.j5024. Review. Erratum in: BMJ. 2018 Jan 12;360:k194.

4.

Disuse Atrophy Accompanied by Intramuscular Ectopic Adipogenesis in Vastus Medialis Muscle of Advanced Osteoarthritis Patients.

Ikemoto-Uezumi M, Matsui Y, Hasegawa M, Fujita R, Kanayama Y, Uezumi A, Watanabe T, Harada A, Poole AR, Hashimoto N.

Am J Pathol. 2017 Dec;187(12):2674-2685. doi: 10.1016/j.ajpath.2017.08.009. Epub 2017 Sep 15.

PMID:
28919112
5.

Coffee and kidney disease.

Kennedy OJ, Roderick P, Poole R, Parkes J.

Int J Clin Pract. 2017 Aug;71(8). doi: 10.1111/ijcp.12980. No abstract available.

PMID:
28836362
6.

What is the association between healthy weight in 4-5-year-old children and spatial access to purposefully constructed play areas?

Poole R, Moon G.

Health Place. 2017 Jul;46:101-106. doi: 10.1016/j.healthplace.2017.05.012. Epub 2017 May 16.

PMID:
28525800
7.

Differences in biomarkers of cartilage matrix turnover and their changes over 2 years in adolescent and adult volleyball athletes.

Boeth H, MacMahon A, Poole AR, Buttgereit F, Önnerfjord P, Lorenzo P, Klint C, Pramhed A, Duda GN.

J Exp Orthop. 2017 Dec;4(1):7. doi: 10.1186/s40634-017-0081-9. Epub 2017 Feb 23.

8.

Deferoxamine Suppresses Collagen Cleavage and Protease, Cytokine, and COL10A1 Expression and Upregulates AMPK and Krebs Cycle Genes in Human Osteoarthritic Cartilage.

Tchetina EV, Markova GA, Poole AR, Zukor DJ, Antoniou J, Makarov SA, Kuzin AN.

Int J Rheumatol. 2016;2016:6432867. doi: 10.1155/2016/6432867. Epub 2016 Nov 30.

9.

Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans.

Strehl C, Maurizi L, Gaber T, Hoff P, Broschard T, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2016 Nov 8;11:5883-5896. eCollection 2016.

10.
11.

Coffee, caffeine and non-alcoholic fatty liver disease?

Kennedy OJ, Roderick P, Poole R, Parkes J.

Therap Adv Gastroenterol. 2016 May;9(3):417-8. doi: 10.1177/1756283X16636765. Epub 2016 Mar 11. No abstract available.

12.

Effects of PVA coated nanoparticles on human immune cells.

Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2015 May 8;10:3429-45. doi: 10.2147/IJN.S75936. eCollection 2015.

13.

Perspectives on Ebola screening at ports of entry in the UK.

Nunn R, Jawad M, Cruickshank H, Poole R, Vass C, Fraser S.

Perspect Public Health. 2015 Mar;135(2):66-7. doi: 10.1177/1757913915570778. No abstract available.

PMID:
25759314
14.

The Creation of the Canadian Connective Tissue Conference (CCTC): Twenty Years on.

Poole AR.

J Cell Commun Signal. 2015 Dec;9(4):303-4. doi: 10.1007/s12079-014-0254-6. Epub 2014 Nov 5. No abstract available.

15.

Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity.

Tchetina EV, Poole AR, Zaitseva EM, Sharapova EP, Kashevarova NG, Taskina EA, Alekseeva LI, Semyonova LA, Glukhova SI, Kuzin AN, Makarov MA, Makarov SA.

Arthritis. 2013;2013:461486. doi: 10.1155/2013/461486. Epub 2013 Jun 25.

16.

Osteoarthritis as a whole joint disease.

Poole AR.

HSS J. 2012 Feb;8(1):4-6. doi: 10.1007/s11420-011-9248-6. Epub 2012 Feb 23. No abstract available.

17.

Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage.

Dejica VM, Mort JS, Laverty S, Antoniou J, Zukor DJ, Tanzer M, Poole AR.

Arthritis Res Ther. 2012 May 14;14(3):R113. doi: 10.1186/ar3839.

18.

Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U.

Arthritis Rheum. 2012 Apr;64(4):1035-45. doi: 10.1002/art.33455. Epub 2011 Nov 10.

19.

Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project.

Nelson AE, Chaudhary S, Kraus VB, Fang F, Chen JC, Schwartz TA, Shi XA, Renner JB, Stabler TV, Helmick CG, Caldwell K, Poole AR, Jordan JM.

Environ Res. 2011 Nov;111(8):1208-14. doi: 10.1016/j.envres.2011.08.002. Epub 2011 Aug 12.

20.

What do measurements of molecular biomarkers in different body fluids really tell us?

Poole AR.

Arthritis Res Ther. 2011 Apr 27;13(2):110. doi: 10.1186/ar3276.

21.

Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis.

Ishijima M, Watari T, Naito K, Kaneko H, Futami I, Yoshimura-Ishida K, Tomonaga A, Yamaguchi H, Yamamoto T, Nagaoka I, Kurosawa H, Poole RA, Kaneko K.

Arthritis Res Ther. 2011 Feb 14;13(1):R22. doi: 10.1186/ar3246.

22.

Immunoassays for collagenase-mediated cleavage of type I and II collagens.

Billinghurst RC, Ionescu M, Poole AR.

Methods Mol Biol. 2010;622:349-66. doi: 10.1007/978-1-60327-299-5_21.

PMID:
20135293
23.

Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.

Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T, Kraus VB, Way A, Thorne A, Wong H, Singer J, Kopec J, Guermazi A, Peterfy C, Nicolaou S, Munk PL, Esdaile JM.

Arthritis Rheum. 2009 May;60(5):1372-80. doi: 10.1002/art.24473.

24.

Biochemical markers of bone turnover and their association with bone marrow lesions.

Hunter DJ, Lavalley M, Li J, Bauer DC, Nevitt M, DeGroot J, Poole R, Eyre D, Guermazi A, Gale D, Totterman S, Felson DT.

Arthritis Res Ther. 2008;10(4):R102. doi: 10.1186/ar2494. Epub 2008 Aug 29.

25.

Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage.

Dejica VM, Mort JS, Laverty S, Percival MD, Antoniou J, Zukor DJ, Poole AR.

Am J Pathol. 2008 Jul;173(1):161-9. doi: 10.2353/ajpath.2008.070494. Epub 2008 May 29.

26.

Influences of menopause, aging, and gender on the cleavage of type II collagen in cartilage in relationship to bone turnover.

Kojima T, Kojima M, Noda K, Ishiguro N, Poole AR.

Menopause. 2008 Jan-Feb;15(1):133-7.

PMID:
18257147
27.

Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.

Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J, Poole R, Eyre D, Guermazi A, Gale D, Felson DT.

Arthritis Res Ther. 2007;9(5):R108.

28.

Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy.

Mullan RH, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, Fearon U, Veale DJ.

Arthritis Rheum. 2007 Sep;56(9):2919-28.

30.

Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D.

Arthritis Rheum. 2007 Jun;56(6):1846-53.

31.

The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis.

Cahue S, Sharma L, Dunlop D, Ionescu M, Song J, Lobanok T, King L, Poole AR.

Osteoarthritis Cartilage. 2007 Jul;15(7):819-23. Epub 2007 Mar 6.

32.
33.

Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.

Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ.

Arthritis Rheum. 2006 Oct;54(10):3152-62.

34.

Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.

Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.

Matrix Biol. 2006 Sep;25(7):419-29. Epub 2006 Jun 30.

PMID:
16919430
35.

Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis.

Mazzuca SA, Poole AR, Brandt KD, Katz BP, Lane KA, Lobanok T.

J Rheumatol. 2006 Jun;33(6):1147-51.

PMID:
16652436
36.

Biologic markers and disc degeneration.

Poole AR.

J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:72-5. Review.

PMID:
16595448
38.

Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.

Aurich M, Mwale F, Reiner A, Mollenhauer JA, Anders JO, Fuhrmann RA, Kuettner KE, Poole AR, Cole AA.

Arthritis Rheum. 2006 Jan;54(1):244-52.

39.

Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.

Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC Jr.

J Rheumatol. 2005 Oct;32(10):1911-7.

PMID:
16206346
40.

Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.

Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM.

J Rheumatol. 2005 May;32(5):896-902.

PMID:
15868627
42.

Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis.

Tiraloche G, Girard C, Chouinard L, Sampalis J, Moquin L, Ionescu M, Reiner A, Poole AR, Laverty S.

Arthritis Rheum. 2005 Apr;52(4):1118-28.

43.

Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.

Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.

Arthritis Rheum. 2005 Mar;52(3):885-91.

44.

Rehabilitation after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind comparison of programs administered over 2 different time intervals.

Beynnon BD, Uh BS, Johnson RJ, Abate JA, Nichols CE, Fleming BC, Poole AR, Roos H.

Am J Sports Med. 2005 Mar;33(3):347-59.

PMID:
15716250
45.

Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.

Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR.

Arthritis Rheum. 2005 Jan;52(1):128-35.

46.

Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.

Aurich M, Squires GR, Reiner A, Mollenhauer JA, Kuettner KE, Poole AR, Cole AA.

Arthritis Rheum. 2005 Jan;52(1):112-9.

47.
48.

The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone.

Holmbeck K, Bianco P, Pidoux I, Inoue S, Billinghurst RC, Wu W, Chrysovergis K, Yamada S, Birkedal-Hansen H, Poole AR.

J Cell Sci. 2005 Jan 1;118(Pt 1):147-56. Epub 2004 Dec 15.

49.

Immunoassays for collagens in chondrocyte and cartilage explant cultures.

Billinghurst RC, Mwale F, Hollander A, Ionescu M, Poole AR.

Methods Mol Med. 2004;100:251-74.

PMID:
15280600
50.

Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.

Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR.

Arthritis Rheum. 2004 Feb;50(2):543-52.

Supplemental Content

Loading ...
Support Center